The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
- Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Mycoplasma tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 202 pages and 15 tables

Table Of Contents

Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Background
Ureaplasma Urealyticum and Mycoplasma Hominis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
Immuno-PCR
QC-PCR
DAP-PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Nucleic-Acid Sequence-Based
Strand Displacement Activation
Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassays
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
V. Italy: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IX. USA: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- JandJ
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus

List of Tables
Major Companies Developing or Marketing Mycoplasma
Tests
France
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
Germany
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market
Segment
Germany
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
Italy
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
Italy
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
Japan
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
Spain
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market
Segment
Spain
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
U.K.
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014-2018 World Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies -Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnosti

2014-2018 World Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies -Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnosti

  • $ 22 400
  • Industry report
  • November 2014
  • by Venture Planning Group

“2014 Automated Microbiology Market--A Global Strategic Outlook” is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the ...

2014-2018 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs

2014-2018 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs

  • $ 13 300
  • Industry report
  • November 2014
  • by Venture Planning Group

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: To identify and evaluate emerging markets and ...

2014-2018 Physician Office Diagnostic Testing Market: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

2014-2018 Physician Office Diagnostic Testing Market: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

  • $ 7 500
  • Industry report
  • November 2014
  • by Venture Planning Group

This 970-page report provides comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive ...

Global Biosensors Market

November 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.